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Light Causes the Isomerization of Retin-A Applied to the Skin 
Recin-A has been a widely used drug, first for treating acne and more 
recently for combating [he wrinkles caused by sun exposure. Some-
wh:!.! surprisingly then, researchers who have been investigating the 
actions of Retin-A. which also goes by rhe name trerinoin, have 
generally failed to consider that it might be converted in the skin to 
other products, some of which might contribute co the drug's thera-
peutic effects. "Scientists have a tendency to attribute tbe effects of 
trctinoin CO tretinoin, ,. says Paul Lehman of the National Center for 
Toxicologic Research in Jefferson, Arkansas. "But J've always 
questioned tha.t. Retinoids arc. very sensitive to light." 
In this issue. Lehman and Andrew MalaDY of the Universiry of 
Washington in Seattle report that light converts tretinoin thar has 
been appl ied to the skin to isotrecinoin plus several additional, but as 
yec unidentified. rcrinoids. They derermined chis by first applying a 
commercial cream containing crennoin CO samples of cadaver skin 
and then exposing the samples to fluorescent light similar to that 
found in an ordinary office environment. When the researchers 
analyzed rhe rctinoids in the skin samples 24 hours later, they found 
that 25% of the original tretinoin remained as tretinoin. Another 
38% had been isomerized to isotretinoin, and the remaining 37% 
had been converted to a complex of retinoids that the researchers 
have nor yet identified. 
The finding suggests. Lehman says. that some of the effects at-
tributed to cretinoin may instcad be produced by isotretinoin, which 
bas also been shown to be active in combating acne and wrinkles. In 
addirion, the work raises concerns that some of the unidentified 
compounds produced by cretinoin might have untoward effects. 
"We don't know what they are or what chey are doing. They could 
be harmful-or not," Lehman says. 
The concern is heightened by the possibiliry that people who are 
trying to avoid wrinkles will use Retin-A for extended time periods 
-years, or even decades. The only experience with the drug uneil 
now has been for treating aCIle, which requires that it be used only 
for months at a rime. "Historically it's very safe for short periods of 
time, bur we don't know whar will happen if you use ir for years," 
Lehman remarks. The next m:p then is to hnd out just what the 
unidentified rcrinoids might be and whatacciviry, if any. they might 
have in the skin. 
Lehman also points out that the rype: of light hitting the skin 
influences the spectrum of compounds to which Recin~A will be 
converted. Previous studies of the drug's activity did nor rake inco 
account the possibility that light might influence the retinoid con-
tenr of rhe skin and possibly ,he study outcome. The researcher 
recommends that in future experiments light exposures should be 
controlled whenever possible. 
Two Groups Make Progress Toward Understanding Melanin Synthesis 
Despite the importance of melanin in determining skin color.acion 
and protecting against the damage caused by exposure to ulrr.aviolet 
light. the basic biologic mechanisms controlling the synthesis of the 
pigmenr are poorly understood. Two p.apers in this issue may help 
remedy this situ.ation. however. In one, Philip Gordon a.nd .Barbara 
Gilchrest of Tufts Universiry in Boston report surprising new in~ 
forma tion abour the intracellular signalling pathway that tells 
hwnan rnelanocytes to make melanin. In the other, researchers from 
the medical schools ar Indiana University and Yale University de-
scribe research tbat should help provlde a better undentanding of 
how the gene for a key enzyme in the mel.anin synthetic pathway is 
controlled. 
Most research on the control of melanin synthesis h.as been done 
on mouse melanoma cells, primarily because they grow readily in 
cuirure, whereas researchers have had trouble culturing normal 
human melanocytes. Recently, however, Gordon and Gilchrest de-
vised an effective culture system for human melanocyres. While 
exploring melanogenesis in tbese ceUs they made an unexpected 
observation. 
When melanocytes are exposed to ultraviolet radiation they re-
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spond by making more melanin. In the mouse melanoma celis, the 
"second messenger" that conveys the signal (0 make more melanin 
in response co such stimuli appears to be cyclic AMP (3',5'-adeno-
sine monophosphate). But when the Tufts workets tried to stimu-
late melanogenesis in human melanocytes with cyclic AMP mimics, 
they gO[ no response. " W e came to the conclusion that cyclic AMP 
is not the intracellular mediator of pigmentation in man," Gordon 
says, " It goes against what is considered dogma in our line of work" 
Gordon and Gilchrest now have evidence for a possible alterna-
tive [Q cycl ic AMP involvement in human melanogenesis. They 
have found chat a mimic of another important second messenger, 
namely, diacylglycerol. does stimulate melanin formation in human 
melanocytcs. It apparently works through an enzyme called protein 
kinase C that is a known target of diacylglycerol and has been 
widely implicated in conrrolling celJular activities. The Tufts 
workers note that this is apparently the first information regarding 
the nature of the signalling pathway that leads to melanogenesis in 
human cells. 
The researchets do not yet know how diacy lglycerol and protein 
kinase C activity might lead to melanin formation. The effect de-
pends on the protein synthesis, however. and this Ilnding suggests 
that the signalling pathway may trigger increased gene expression, 
perhaps stimulating the activity of one or more of the genes encod-
ing the enzymes of the melanin synthesis pathway, 
One of the key enzymes in this pathway is the first, tyrosinase. 
which converts the amino acid cyrosine to dihydroxyphenylalanine. 
Also in this issue, Byoung K won. Asifa Haq, Mark Wakulchik. and 
Daniel Keslter of Indiana University School of Medicine in Bloom-
ington, David Barton, Uta Francke, and Ruth Halaban of Yale 
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University School of Medicine in New Haven, M. Lynn Lamoreux 
ofTe_xas A&M University in College Station, and J. Barry Whitney 
of the Medical College of Georgia in Augusta report that they have 
confirmed the chromosomallocarion of the mouse tyrosinase gene. 
It occurs, as other work had predicted. in or near the albino locus on 
mouse chromosome 7, 
Establishing the location of this gene at that chromosomal site is 
important, K won explains, because of the critical role that tyrosin-
ase plays in melanin synthesis, Moreover. several other genes 
known to be importanc for controlling mouse developmenc are 
located near rhe albino locus. It may now be possible to use the 
tyrosinase gene as a starting point for isolating those other genes. 
K won and his colleagues have also idenrilled the promoter region 
of the mouse ryrosinase gene and determined irs nucleotide se-
quence. "This is rotaJ ly new," Kwon says, "and should be helpful 
for analyzing the concrol of the gene." Promoters are regulatory 
sequences that help control when and where genes are turned on. 
Regulation of the tyrosinase gene is complex , Kwon poims out, it 
responds to u.lrravioler radiation and hormones. And this complex-
ity may be reflected in the complexity of the gene's promoter. 
Kwon and his colleagues plan to make systematic mutants of the 
promoter region to see if they ca.n identify the elements that allow 
the gene to respond to differem stimuli. 
The work of Gordon and Gilchrest and of the K won group is 
providing researchers with twO possible approaches for studying the 
control of melanin synthesis. They can begin with the pathway that 
conveys signa.ls to make melanin to the cell interior, or they can 
begin with a key gene in the synthetic pathway, Perhaps at some 
point the [\.\' 0 approaches may merge. 
Human Langerhans Cells May Mature Into Dendritic Cells 
The Langerhans cells are thought ro playa major role in initiating 
im.mune responses to foreign pathogens that try to invade the body 
through the skin . .But, says Gerold Schuler of the Universiry of 
Innsbruck, Austria, freshly isolated Langerhans cdls have little abil-
ity to activate T cells. a necessary preliminary to inducing an im-
mune response. 
In this issue, Schuler and Nikolaus Romani, Angela Lenz. Herta 
Glassl, Hella Stossl. and Ursula Stanzl of the University of 10115-
bruck and O tto Majdic of the University of Vienna report that 
human Langerhans cells may firs t have to mature into dendritic ceLIs 
and mjgrate into the lymph nodes before they gain the ability to 
aCrlvatc T cells, The Ilnding may provide clues that will enable 
researchers to design drugs that can be used to treat sk.in diseases 
caused by aberrant immune responses. 
The current wotk is an outgrowth of previous research in which 
Schuler and his colleagues showed that mouse Lange,rhans cells 
undergo major changes in both appearance and function when 
maintained in cultured. "Right after isolation, they have many mac-
rophage features," Schuler says, "but in culrure they change into 
cells virtually indistinguishable from the dendritic cells in the skin-
draining lymph nodes." They also gain the abiliry, which is lacking 
in the freshly isolated mouse Langerhans celi, to be potent stimula-
tors of resting T cells. "The message is that the resident Langerhans 
cell is an immature precursor of rhe denuitic cell," Schuler con-
cludes, 
The Austrian workers wanted to Ilnd out if human Langerhans 
cells behave the same way, and they do, at least with regard to 
appearance. The Schuler group has also shown that the cultured 
human cells are very active in stimulating T cells. but the re-
searchers do not yer know whether this means that the cells' func-
tion has actually increased during the culture procedure. Uncil very 
recently, the investigators were not able to obtain enough of the 
freshly isolated human cells to get a baseline measure of their activ-
ity. They are now able to do this, however, and the necessary func-
tinal studies are underway, 
According to Scbuler. rwo factors produced by keratinocytes. 
namely, granulocyte-macrophage colony stimulating factor and in-
terleukin-l , mediate the maturation of the mouse Langerhans cells, 
The Austrian researchers want to find our if the maturation of 
human Langerhans cells also depends on the keratinocyte factors . If 
it does, then it migh t be possible to devise drugs that can block or 
stimulate the maturation of the human cells. A maturation blocker 
might be useful, for example, in treating skin aJlergies or autoim-
mune conditions, in which the immune responses are overactive. 
